Images in Pathology: Alzheimer's Disease

Total Page:16

File Type:pdf, Size:1020Kb

Images in Pathology: Alzheimer's Disease JOURNAL OF INSURANCE MEDICINE Copyright Q 2002 Journal of Insurance Medicine J Insur Med 2002;34:127±130 GRAPHICS SECTION Images in Pathology: Alzheimer's Disease Venita Jay, MD, FRCPC The review describes the histopathology and pathophysiology of Al- Address: Manulife Reinsurance, 200 zheimer's disease. Bloor Street East, Toronto, Ontario M4W1E5, Canada. Key words: Alzheimer's disease, dementia, histopathology. early a century ago, Alois Alzheimer de- occupational status and fewer years of edu- Nscribed the ®rst case of the disease that cation.3 now bears his name.1 Alzheimer's ®rst en- A clinical diagnosis of AD can be quite ac- counter with this fateful case was in 1901, curate in the hands of an experienced physi- when a 51-year-old woman was admitted cian. Clinical workup includes screening for with aphasia, poor memory, lack of orienta- other causes of dementia in the elderly and tion, paranoid ideation, unpredictable behav- exclusion of other etiologies (eg, hypothy- ior, hallucinations and severe cognitive de®- roidism, drug-induced encephalopathy, cits. After her death in 1906, Alzheimer re- chronic subdural hematoma, brain tumor). ported the autopsy ®ndings in a landmark While neuropsychological testing, metabolic presentation entitled, ``On a Peculiar Disease neuroimaging, and cerebrospinal ¯uid tau Process of the Cerebral Cortex.'' Alzheimer's levels have been used to increase con®dence original pathological description of cerebral in the probability that the dementia is due to atrophy, neuro®brillary change and loss of AD, an unequivocal diagnosis of AD can be neurons, remains remarkably accurate to this rendered only on neuropatholgical examina- day.1 tion of brain tissue.5,6 By CT or MR imaging, Today, Alzheimer's disease (AD) is recog- there is evidence of cortical atrophy (notably nized as the most common cause of dementia the medial temporal lobe), with parietotem- in the elderly, accounting for over 50% of cas- poral hypoperfusion on positron emission to- es.2,3 The most potent risk factor for AD is mography (PET) and single photon emission increasing age and the presence of the apo- computed tomography (SPECT).2 This selec- lipoprotein e4 allele. The lifetime risk of AD tive early involvement of the medial temporal for an individual without the e4 allele is 9%, lobe is utilized in the diagnosis of AD by neu- while the lifetime risk of an individual car- roimaging.5 rying at least one e4 allele is 29%.4 AD is From a pathological perspective, the brain more common among women than men with in AD is reduced in weight, with especially a ratio of 1.2 to 1.5.3 Other risk factors impli- pronounced atrophy of the medial temporal cated in some studies include head injury, lobe, and atrophy of the temporal, parietal family history of dementia, lower income and and frontal association cortices.5,6 Primary 127 JOURNAL OF INSURANCE MEDICINE cortical areas (primary motor, sensory and vi- phorylated as well as abnormally phosphor- sual cortex) and most subcortical structures ylated tau protein.7 Normal adult tau is a sol- are relatively preserved. The lateral ventricles uble microtubule binding protein that is pri- are dilated secondary to cerebral atrophy. The marily localized in axons and plays an im- hippocampus and amygdala are atrophic. portant role in the polymerization and The locus ceruleus often shows loss of pig- stabilization of microtubules.5 The abnormal- ment. ly phosphorylated tau of AD is less able to At a microscopic level, there is diffuse loss bind microtubules, presumably leading to of large pyramidal neurons in the cerebral microtubule depolymerization, disrupted ax- cortex in AD, especially involving the multi- onal transport, compromised synaptic trans- modal association cortices.6 There is also neu- mission, and ultimately neuronal death.5 ronal loss in the hippocampus, amygdala, As shown in Figure 1B, another patholog- basal forebrain, and locus ceruleus. There is ical hallmark of AD is the neuritic plaque. a substantial loss of synapses, which corre- Neuritic plaques have a dense core of extra- lates with the degree of cognitive impair- cellular amyloid surrounded by an amyloid ment. Concomitant with the cerebral atrophy, corona, in which dystrophic neurites (con- there is astrocytic gliosis. taining abnormal tau/paired helical ®la- Alois Alzheimer used the newly developed ments) and processes of reactive microglia Bielschowsky's silver staining method to are incorporated. Large numbers of neuritic demonstrate the neuro®brillary tangles in plaques accumulate in the cerebral cortex in neurons of the cerebral cortex of his famous AD. Senile plaques of aging (nonneuritic se- patient.1 The Bielschowsky stain continues to nile plaques or diffuse plaques) are seen in be widely used to demonstrate AD patholo- elderly people without dementiaÐthey lack gy. Figures 1A and 1B illustrate the classical the amyloid core, dystrophic neurites, and pathological ®ndings in ADÐneuro®brillary the in¯ammatory microglial response. On tis- tangles and neuritic plaques in a section of sue sections, amyloid is demonstrated by the cortex stained by the Bielschowsky stain. congo red stain or by ¯uorescence after thio- The neuro®brillary lesions of AD present ¯avin staining. in the form of neuro®brillary tangles, neuro- Other pathological ®ndings on microscopy pil threads, and neuritic plaques.2,5,6 Neuro- include Hirano bodies and granulovacuolar ®brillary tangles are ®lamentous inclusions degeneration (GVD) in the neurons of the within the neuron body and proximal den- hippocampus (clear vacuoles pushing the cy- drites (Figure 1A). Whereas, neuropil threads toplasm and containing a basophilic granule). (which have a thread-like appearance) are In some studies, the number of neurons af- found in distal dendrites and axons.5 fected by GVD correlated with the duration At an ultrastructural level, neuro®brillary of dementia.2 In AD patients, there is also ce- tangles are composed principally of paired rebrovascular pathology with deposition of helical ®laments, which are intraneuronal amyloid in blood vessels (cerebral amyloid proteinaceous structures composed of an ab- angiopathy). normal form of the tau protein.2,5,6 Paired he- In AD, there is a highly selective distribu- lical ®laments accumulate in neuronal cell tion of neuro®brillary lesions and to a lesser bodies (neuro®brillary tangles), in neuronal extent of neuritic plaques. Regions most af- processes throughout the cortex (neuropil fected with neuro®brillary tangles are the me- threads), and in distended neuronal process- dial temporal lobe, amygdala, the association es (dystrophic neurites) around the extracel- cortices, and the nucleus basalis of Meynert. lular amyloid deposits in the neuritic plaque Within the entorhinal cortex, there is also a of AD. selective involvement of certain neuronal lay- Biochemically, neuro®brillary tangles are ers (layers II and IV) with relative sparing of composed of a poorly soluble hyperphos- layers III, V, and VI. It is noteworthy that the 128 JAYÐPATHOLOGY OF ALZHEIMER'S DISEASE Figures 1A and 1B. Section of cerebral cortex stained by the Bielschowsky stain demonstrating neuro®brillary tangles (arrowheads) (A, high power view) and several neuritic plaques (arrowheads) (B, medium power view). large projection neurons in layers II and IV In terms of correlating pathology with clin- link the hippocampus with the association ical severity, there is a strong correlation be- cortices.5 This disruption of the neural link be- tween the density of neuro®brillary tangles tween the hippocampus and the rest of the and the severity of dementia (speci®cally brain contributes to the amnesia in AD.5 neuro®brillary tangles in the neocortical as- 129 JOURNAL OF INSURANCE MEDICINE sociation areas).5 Correlations between senile 21) have been found.3 Other mutations have plaques and dementia have been more con- been found to involve genes on chromosome troversial, but mature neuritic plaques with 14 (presenilin-1 gene) and chromosome 1 an amyloid core do correlate with dementia, (presenilin-2 gene).3 albeit not as strongly as neuro®brillary tan- A problem in terms of a diagnosis based gles.5 on tissue pathology alone is the fact that the The neuro®brillary tangles and neuritic microscopic lesions of AD may occur to a plaque lesions of AD are accompanied by an minimal or modest degree in nondemented in¯ammatory reaction including proliferation elderly people. As a practical guide, the ®nd- of microglia and astrocytes, prompting re- ing of neuro®brillary tangles in a neocortical search into the role of anti-in¯ammatory brain biopsy allows for a relatively certain di- medication in AD.2 agnosis of AD.2 If neuro®brillary tangles and Several neurotransmitter systems are af- neuritic plaques are abundant throughout the fected in AD. There is a severe loss of cholin- neocortex and the hippocampus at autopsy, ergic neurons in the nucleus basalis of Mey- then a neuropathologic diagnosis of AD is nert of the forebrain.5 Abnormalities of the relatively straightforward.2 Neuro®brillary cholinergic systems form the basis of phar- tangles without neuritic plaques are also en- macotherapeutic interventions aimed at en- countered in a number of other ``tauopathies'' hancing cholinergic activity. Cholinesterase such as supranuclear palsy and dementia inhibitors are the only medications approved pugilistica,2,7 but a combination of tangles, by the U.S. Food and Drug Administration as neuritic plaques, vascular amyloid, and gran- treatment for AD.3 In addition to cholinergic ulovacuolar degeneration is diagnostic of AD. neurons, other neurotransmitter systems are This article is intended only as a brief overview also affected including the locus ceruleus of the pathology and does not represent an ex- (norepinephrine) and the raphe nuclei (sero- haustive review of the pathological or clinical lit- tonin).5 erature on the subject. The amyloid protein in the neuritic plaques and vessels in AD is beta-amyloid (beta/A4 REFERENCES protein, amyloid b-peptide). It is derived from a larger protein, the A4 (amyloid pre- 1.
Recommended publications
  • International
    2021 Revision 3 Our Commitment to the Customer We at ScyTek Laboratories, Inc. have committed ourselves to producing only the highest quality products for the laboratory market. Since the company was founded in 1991, ScyTek has continued to grow at a rapid rate as a result of our commitment to continuous improvement of each and every product line. In addition, aggressive pricing through vigilant cost containment and continuous improvements in efficiency combined with our commitment to quality have helped to foster strong customer bonds. While the majority of our business consists of producing custom reagents for the resale/OEM market, we still insist on providing only the highest quality service for those customers that use the product in their own laboratories. Being a primary manufacturer allows ScyTek to continually identify areas that can be improved through the implementation of Kaizen and other manufacturing management techniques. Being a primary manufacturer also allows the customer to have maximum flexibility in the products specifications making ScyTek an ideal manufacturing partner. ScyTek has the ability to produce and vial products in various environmental conditions up to Class 1000. For our OEM customers, we have the capability of producing most any liquid or dry blend for the laboratory and can customize packaging to meet nearly any requirement. Whether the product is an off- the-shelf item, or one made specifically to meet the customer’s needs, we are committed to delivering the product when expected and matching the anticipated specifications. As the President of ScyTek Laboratories, Inc., I encourage you to contact me directly with any questions or comments regarding the performance of our company or our products.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,993,927 B2 Frangioni (45) Date of Patent: Aug
    US007993 927B2 (12) United States Patent (10) Patent No.: US 7,993,927 B2 Frangioni (45) Date of Patent: Aug. 9, 2011 (54) HISTOLOGY METHODS FOREIGN PATENT DOCUMENTS WO WO96, 17628 6, 1996 (75) Inventor: John V. Frangioni, Wayland, MA (US) WO WO98,22146 5, 1998 WO WO98,48838 11, 1998 (73) Assignee: Beth Israel Deaconess Medical Center, WO WO 98.48846 11, 1998 Inc., Boston, MA (US) WO WO O2/O98885 12/2002 OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this Parungo et al., “Intraoperative identification of esophageal sentinel patent is extended or adjusted under 35 1ymph nodes with near-infrared fluorescence imaging'.--- - - - - J. Thorac. U.S.C. 154(b) by 1070 days. Cardiovasc. Surg., Apr. 2005; 129: 84.* Kim et al., “Near-infrared fluorescent type II quantum dots for sen (21) Appl. No.: 11/824,915 tinellymph node mapping”. Nature Biotechnology 22,93-97 (Jan. 1, 2004).* (22) Filed: Jul. 3, 2007 gatesBrinkley, with "A Dyes, Brief Haptens, Survey ofand Methods Cross-Linking for Preparing Reagents'. Protein Perspec Conju O O tives in Bioconjugate Chemistry, pp. 59-70, C. Meares (Ed.), ACS (65) Prior Publication Data Publication, Washington, D.C. (1993). US 2008/OO7356.6 A1 Mar 27, 2008 Frangioni, J.V., “In vivo near-infrared fluorescence imaging. Curr. • 1- s Opin. Chem. Biol. 7:626-634 (2003). O O Hilger et al., “Near-infrared fluorescence imaging of HER-2 protein Related U.S. Application Data over-expression in tumour cells'. Eur, Radiol., 14:1124-1129 (2004). Li et al., “Tumor Localization Using Fluorescence of Indocyanine (60) Provisional application No.
    [Show full text]
  • Catalogcatalog
    CATALOGCATALOG 25052505 ParviewParview RoadRoad •• Middleton,Middleton, WIWI 53562-257953562-2579 •• 800-383-7799800-383-7799 www.newcomersupply.comwww.newcomersupply.com 20212021 ABOUT US IHC Mission Keeping it real: Our job is to help you get your job done! Everything we do is designed with your needs in mind. Our goal is to make sure your goals are met. Keeping the lines of communication open: Our technical support staff is ready to help you solve problems, resolve concerns, and make sure that your procedures run as smoothly as possible. Keeping prices competitive: We take pride in making sure our products arrive at your lab with the fairest price possible. Keeping a sense of humor: Life is Good! Don’t forget that. We won’t. If you’re having a bad day, don’t worry, it’s our joy to make sure your day is full of HISTOCALIFRAGILISTICEXPIALIDOCIOUS! We work hard to bring you the best histology supply services available. Please call 800-383-7799 or e-mail [email protected] anytime with any questions or comments. 1 ® 2505 Parview Road, Middleton, WI 53562-2579 • 800-383-7799 • www.newcomersupply.com 78 ORDERING INFORMATION PLACING AN ORDER RETURNS To place an order, contact customer service by phone, fax, Contact Newcomer Supply prior to returning any product. mail or email. Our experienced staff is available and ready If you have a problem with a product or shipment, call us to help you find the histology laboratory products you need. within five business days of the issue. Returns without a To see our current product listings, please visit our website.
    [Show full text]
  • Are Routine Methods Good Enough to Stain Senile Plaques and Neurofibrillary Tangles in Different Brain Regions of Demented Patie
    Psychiatria Danubina, 2011; Vol. 23, No. 4, pp 334-339 Original paper © Medicinska naklada - Zagreb, Croatia ARE ROUTINE METHODS GOOD ENOUGH TO STAIN SENILE PLAQUES AND NEUROFIBRILLARY TANGLES IN DIFFERENT BRAIN REGIONS OF DEMENTED PATIENTS? Paraskevi Mavrogiorgou1,3, Hermann-Josef Gertz2, Ron Ferszt3, Rainer Wolf1, Karl-Jürgen Bär1 & Georg Juckel1,3 1Department of Psychiatry, Ruhr University, Bochum, Germany 2Department of Psychiatry, University Leipzig, Germany 3Department of Psychiatry, Charité – University Medicine Berlin, Campus Mitte, Berlin, Germany received: 10.8.2010; revised: 11.9.2011; accepted: 24.10.2011 SUMMARY Introduction: Numerous clinical cases have been reported showing the clinical picture of dementia but not meeting the neuropathological criteria for Alzheimer’s dementia (AD). Different methods used to stain senile plaques (SPs) and neurofibrillary tangles (NFTs) might account for this discrepancy. Subjects and methods: Here, brains of 11 patients with dementia were examined. Cryosections and paraffin sections from 6 different brain regions (frontal medial, temporal medial and occipital gyrus, hippocampus, superior parietal lobe and cerebellum) of all cases were stained with Bielschowsky, Campbell, Gallyas and Congo red stains each. Results: The study shows that the Bielschowsky silver stain is insufficient for detecting SPs and NFTs, whereas two other methods proved to be more accurate. SPs were found in similar frequency in all brain regions examined (exception: cerebellum). The highest amount was shown with Campbell silver stain in paraffin sections. In Congo red only 25 percent of these SPs were stained, which is probably due to a great number of them not containing any amyloid. NFTs were found almost exclusively in the hippocampus.
    [Show full text]
  • Quantitative and Histomorphological Studies on Age-Correlated Changes in Canine and Porcine Hypophysis Lakshminarayana Das Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1971 Quantitative and histomorphological studies on age-correlated changes in canine and porcine hypophysis Lakshminarayana Das Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Animal Structures Commons, and the Veterinary Anatomy Commons Recommended Citation Das, Lakshminarayana, "Quantitative and histomorphological studies on age-correlated changes in canine and porcine hypophysis" (1971). Retrospective Theses and Dissertations. 4873. https://lib.dr.iastate.edu/rtd/4873 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. 71-26,847 DAS, Lakshminarayana, 1936- QUANTITATIVE AND HISTOMORPHOLOGICAL STUDIES ON AGE-CORRELATED CHANGES IN CANINE AND PORCINE HYPOPHYSIS (VOLUMES I AND II). Iowa State University, Ph.D., 1971 Anatomy• University Microfilms, A XEROX Company, Ann Arbor. Michigan Quantitative and histomorphological studies on age-correlated changes in canine and porcine hypophysis py Lakshminarayana Das Volume 1 of 2 A Dissertation Submitted to the Graduate Faculty in Partial Fulfillment of The Requirements for the Degree of DOCTOR OP PHILOSOPHY Major Subject:
    [Show full text]
  • 1. Aldehyde Fuchsin - Can Be Used to Stain Pancreatic Islet Beta Cell Granules 2
    1. Aldehyde Fuchsin - can be used to stain pancreatic islet beta cell granules 2. Alician Blue - a Mucin stain (a category of histology stains, listed below) - can stain mucins and mucosubstances blue (due to the copper in the stain) 3. Alizarin Red S - can be used to identify calcium in tissue sections - used on the Dupont ACA analyzer to measure serum calcium photometrically 4. Alkaline Phosphatase - can be used to stain endothelial cells 5. Azan Stain - can be used to differentiate osteoid from mineralised bone 6. Bielschowsky Stain - can be used to show reticular fibres - used for showing neurofibrillary tangles and senile plaques - uses the chemical element silver (Ag) 7. Cajal Stain - can be used on nervous tissue. 8. Congo Red - used to stain amyloid fibres (to appear orange/red). 9. Cresyl Violet - will stain both neurons and glia - bonds with acidic parts of cells such as ribosomes, nuclei and nucleoli 10. Eosin - commonly used for general histology staining when paired with haematoxylin - see Hematoxylin and Eosin (H&E) 11. Fontana-Masson - uses the chemical element silver (Ag) - stains argentaffin granules and melanin black - while also staining nuclei pink/red and cytoplasm light pink - a specific example of a Melanin Stain (general category of histology stains) 12. Giemsa Stain - a Romanowski (also written "Romanowsky") type stain - used for peripheral blood smears, i.e. a thin layer of blood smeared on a microscope slide and used for bone marrow. - used to study parasites and malaria 13. Golgi Stain - can be used to stain neurons 14. Gomori Trichrome - trichrome histology stains are formed from a mixture of three dyes - Gomori's trichrome stains connective tissue and collagen (green or blue), muscle, keratin and cytoplasm (red) and nuclei (grey/blue/black) 15.
    [Show full text]
  • Laboratory Emerging Pathogens Initiative (Epi) Roll up Modifications Technical and User Manual
    LABORATORY EMERGING PATHOGENS INITIATIVE (EPI) ROLL UP MODIFICATIONS TECHNICAL AND USER MANUAL PATCH LR*5.2*281 Version 5.2 June 2004 Department of Veterans Affairs VistA Health System Design and Development Preface The Veterans Health Information Systems and Architecture (VistA) Laboratory Emerging Pathogens Initiative (EPI) Rollup Modifications Patch LR*5.2*281 Technical and User Manual provides assistance for installing, implementing, and maintaining the EPI software application enhancements. Intended Audience The intended audience for this manual includes the following users and functionalities: • Veterans Health Administration (VHA) facility Information Resource Management (IRM) staff (will be important for installation and implementation of this package) • Laboratory Information Manager (LIM) (will be important for installation and implementation of this package) • Representative from the Microbiology section in support of the Emerging Pathogens Initiative (EPI) Rollup enhancements (i.e., director, supervisor, or technologist) (will be important for installation and implementation of this package especially with parameter and etiology determinations; may also have benefit from local functionality) • Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff or persons at the VHA facility with similar function (will be important for implementation of this package given broad-ranging impact on medical centers and cross-cutting responsibilities that extend beyond traditional service lines; may also have benefit from local functionality) • Infection Control Practitioner (likely to have benefit from local functionality) NOTE: It is highly recommend that the Office of the Director (00) at each VHA facility designate a person or persons who will be responsible for the routine implementation of this patch (both at the time of this installation and afterwards) and to take the lead in trouble-shooting issues that arise with the routine functioning of the process.
    [Show full text]
  • Bibliograficzne Z´Ro´Dła Ilustracji
    BIBLIOGRAFICZNE Z´RO´ DŁA ILUSTRACJI Dzięki uprzejmości: Acuson Computed Sonography Corporation, Mountain View, CA (Doppler ultrasonography). Zaczerpnięto z: Agur AMR, Lee M. Grant’s Atlas of Anatomy. 10th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1999 (spinal column). Dzięki uprzejmości: Alzheimer’s Disease Education and Referral Center, a service of the National Institute on Aging (PET scan). Przedrukowano za zgodą: American Cancer Society, Inc. (malignant melanoma). Jennifer Anderson @ USDA-NRCS PLANTS Database (Podophyllum peltatum, Dicentra cucullaria). Zaczerpnięto z: Anderson SC, Poulsen K. Anderson’s Atlas of Hematology. Baltimore, MD: Lippincott Williams & Wilkins; 2003 (pronormoblast, basophilic normoblast, polychromatophilic normoblast, orthochromatophilic normoblast, reticulocyte, erythrocyte, plasmablast, proplasmacyte, plasma cells: plasmacytes, lymphoblast, lymphocyte, monoblast, premonocyte, monocyte, eosinophilic myelocyte, eosinophilic metamyelocyte, eosinophilic band, eosinophil, myeloblast, promyelocyte, neutrophilic myelocyte, neutrophilic metamyelocyte, neutrophilic band, neutrophil, basophilic myelocyte, basophilic metamyelocyte, basophilic band, basophil, megakaryoblast, promega- karyocyte, megakaryocyte, platelets, hypersegmentation, Pelger-Huët, Döhle body, Faggot cell, LE cell, cleaved cell, hairy cell, Dutcher body, Mott cell, Chédiak-Higashi granules, bilobed plasma cell, bacteria: spirochetes, stomatocytosis). Zaczerpnięto z: Baker CL. The Hughston Clinic Sports Medicine Book. 1st ed. Baltimore, MD:
    [Show full text]
  • WO 2012/076010 Al 14 June 2012 (14.06.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/076010 Al 14 June 2012 (14.06.2012) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every G 33/52 (2006.01) G01N 33/86 (2006.01) kind of national protection available): AE, AG, AL, AM, G01N 33/53 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/DK201 1/000148 HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 6 December 201 1 (06.12.201 1) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/419,949 6 December 2010 (06. 12.2010) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (71) Applicant (for all designated States except US): DAKO UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, DENMARK A S [DK/DK]; Produktionsvej 42, DK-2600 TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, Glostrup (DK).
    [Show full text]
  • Education Guide Special Stains Dako Provides Cancer Diagnostic Products for Leading Reference Laboratories, Hospitals and Other Clinical and Research Settings
    PATHOLOGY Education Guide Special Stains Dako provides cancer diagnostic products for leading reference laboratories, hospitals and other clinical and research settings. Our instrumentation portfolio is complemented by a full line of antibodies, pharmDx™ assays, detection systems and ancillaries. Consider Dako for all your laboratory needs. Guide to Special Stains Editor Sonja Wulff Dako Fort Collins, Colorado, USA Technical Advisor Laurie Hafer, PhD Dako Cambridge, Massachusetts, USA Contributors Mary Cheles, MPH, HTL, DLM (ASCP) Dako Carpinteria, California, USA Rick Couture, BS, HTL (ASCP) Dako Cambridge, Massachusetts, USA Jamie M. Holliday, HT (ASCP) Dako Carpinteria, California, USA Susie Smith, BS, HTL (ASCP) Dako Cambridge, Massachusetts, USA David A. Stanforth, BS Dako Carpinteria, California, USA ©Copyright 2004 Dako, Carpinteria, California, USA. All rights reserved. No part of this book may be reproduced, copied or transmitted without written permission. US $25 Table of Contents Introduction to Special Stains Historical Perspective 1; Clinical Relevance 2 The Biology of Special Stains The Cell 5; Tissue 6; Pathogens 8 The Chemistry of Special Stains Basic Chemistry 14; Principles Of Staining 15 Fixation and Tissue Processing Fixation 17; Specimen Processing 21 Staining Methods: Nucleus and Cytoplasm Hematoxylin and Eosin 24; Nucleic Acids 29; Polychromatic Stains 31 Staining Methods:Connective Tissue, Muscle Fibers and Lipids Connective Tissue 34; Reticular Fibers 35; Basement Membranes 36; Elastic Fibers 38; Mast Cells
    [Show full text]
  • Molecular Pathology Catalog
    With a family of Xmatrx® systems, you have the freedom to Molecular Pathology Catalog Molecular Pathology Catalog attend to more demanding tasks while delivering high-quality and standardized results every time 2014 - 2015 (International) Microtome to Microscope IHC | Special Stains | FISH* & ISH | miRNA | Multiplex IHC & ISH | in situ PCR 2014 - 2015 All-in-One All-at-Once • TheT World’s First and Only Fully Automated Front-end FISH Processing System • RRun up to 40 slides under multiple protocols • RReduce hands-on tech time from 7.5 hours to 30 minutes ThreeT Simple Steps Load Click View Doc. No. 937-4083.0 *Optional Software for Research Use Only In the U.S., call +1 (800) 421-4149 © 2014 BioGenex Laboratories, Inc. All Rights Reserved ISO 13485:2003 Outside the U.S., call +91-40-27185500 www.biogenex.com FM 78972 For distribution worldwide except USA and Canada Dear Customer, We are pleased to present the BioGenex Molecular Pathology Catalog for 2014 - 2015. As a vertically integrated company we develop, manufacture and market highly innovative and fully automated systems for cancer diagnosis, prognosis and therapy selection. Xmatrx® systems redefine complete automation for the molecular pathology laboratory and standardize all the steps from baking through final cover-slipping in three simple steps - Load, Click and View. Compared to any other system on the market, Xmatrx® systems offer clean intense stain(s), automate more assay steps, and enable automation of technologies for the future molecular pathology laboratory. • Xmatrx®
    [Show full text]
  • Download PDF File
    Folia Morphol. Vol. 74, No. 2, pp. 137–149 DOI: 10.5603/FM.2015.0024 R E V I E W A R T I C L E Copyright © 2015 Via Medica ISSN 0015–5659 www.fm.viamedica.pl Essential and current methods for a practical approach to comparative neuropathology D. De Biase, O. Paciello Department of Veterinary Medicine and Animal Production, Unit of Pathology, University of Naples Federico II, Napoli, Italy [Received 24 September 2014; Accepted 2 October 2014] The understanding of mechanisms that provoke neurological diseases in humans and in animals has progressed rapidly in recent years, mainly due to the advent of new research instruments and our increasing liability to assemble large, complex data sets acquired across several approaches into an integrated representation of neural function at the molecular, cellular, and systemic levels. Nevertheless, morphology always represents the essen- tial approaches that are crucial for any kind of interpretation of the lesions or to explain new molecular pathways in the diseases. This mini-review has been designed to illustrate the newest and also well-established principal methods for the nervous tissue collection and processing as well as to de- scribe the histochemical and immunohistochemical staining tools that are currently most suitable for a neuropathological assessment of the central nervous system. We also present the results of our neuropathological stu- dies covering material from 170 cases belonging to 10 different species of mammals. Specific topics briefly addressed in this paper provide a technical and practical guide not only for researchers that daily focus their effort on neuropathology studies, but also to pathologists who occasionally have to approach to nervous tissue evaluation to answer questions about neuro- pathology issues.
    [Show full text]